Gambogic acid inhibits the catalytic activity of human topoisomerase IIalpha by binding to its ATPase domain.
第一作者:
Yuxin,Qin
第一单位:
Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, PR China.
作者:
主题词
腺苷三磷酸酶类(Adenosine Triphosphatases);腺苷三磷酸(Adenosine Triphosphate);抗原, 肿瘤(Antigens, Neoplasm);抗肿瘤药(Antineoplastic Agents);细胞凋亡(Apoptosis);印迹法, 蛋白质(Blotting, Western);细胞增殖(Cell Proliferation);DNA损伤(DNA Damage);DNA拓扑异构酶类, Ⅱ型(DNA Topoisomerases, Type II);DNA结合蛋白质类(DNA-Binding Proteins);抗药性, 肿瘤(Drug Resistance, Neoplasm);依托泊甙(Etoposide);流式细胞术(Flow Cytometry);基因, MDR(Genes, MDR);人类(Humans);水解作用(Hydrolysis);JNK丝裂原活化蛋白激酶类(JNK Mitogen-Activated Protein Kinases);肿瘤(Neoplasms);磷酰化(Phosphorylation);RNA干扰(RNA Interference);表面等离激元(Surface Plasmon Resonance);拓扑异构酶II抑制剂(Topoisomerase II Inhibitors);肿瘤干细胞测定(Tumor Stem Cell Assay);山吨类(Xanthones)
DOI
10.1158/1535-7163.MCT-07-0147
PMID
17876042
发布时间
2020-09-30
- 浏览7

Molecular cancer therapeutics
2429-40页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文